BAFNA PHARMACEUTICALS LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 104.8 INR | -4.42% |
|
+10.55% | +13.91% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Bafna Pharmaceuticals Limited is an India-based company, which is engaged in the manufacture of drugs and medicines and selling a reputed brand namely RARICAP. The Company caters to both domestic and international market. It operates in generic pharmaceutical segment. The Company manufactures 336 licensed pharmaceutical formulations and have globally registered 78 of its products. It supplies its products to the United Kingdom, Europe, and Australian markets. The Company's Grantlyon facility has the capability to supply both small-scale clinical trial quantities and commercial-scale requirements. The Companyâs subsidiary is Bafna Lifestyles Remedies Limited.
Sector
Pharmaceuticals
Calendar
26/05/2024
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +13.91% | 29.7M | |
| +18.67% | 43.74B | |
| +21.99% | 22.26B | |
| +16.41% | 14.9B | |
| +9.03% | 13.39B | |
| +40.48% | 12.12B | |
| -9.64% | 6.92B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.41% | 5.47B |
- Stock Market
- Equities
- BAFNAPH Stock
- News Bafna Pharmaceuticals Limited
- Bafna Pharmaceuticals Resumes Commercial Production of Manufacturing Units in Chennai, India
